Zitter Health Insights Pool

Explore Products

Biosimilar Launch Compass

A snapshot 360° view of access related to the launch of biosimilars in both oncology and non-oncology specialty categories.

Take action:

Schedule a Demo

  • Understand the impact biosimilars have on payer management of specialty drugs
  • Assess whether or not payer management and treatment algorithms apply to all indications of the innovator drug, or only the approved indication for the biosimilar
  • Evaluate the cost differential from innovator products required by payers to take advantage of biosimilars
  • Have a comprehensive view of the issues related to the latest biosimilar generic launches in specialty categories

The Biosimilar Launch Compass uses established ZHI products to compare and contrast between current and potential access issues for all impacted drugs – both biosimilars and branded agents

Schedule A Demo